Call for Applications: 2019-2020 Awards Supported by the Oklahoma Nathan Shock Center

Sponsor: Oklahoma Nathan Shock Center

Award: Between $5,000 and $20,000 depending on the specific needs of the applicant

Due Date: Applications Due June 1

BRAIN Initiative: Secondary Analysis and Archiving of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)

Sponsor: National Institutes of Health

Award: Issuing IC and partner components intend to commit an estimated total of $4 million to fund eight awards in fiscal year 2020.

Due Date: September 6, 2019, and June 11, 2020, by 5 p.m. local time of applicant organization.

BRAIN Initiative: Tools to Facilitate High-Throughput Microconnectivity Analysis (R01 Clinical Trial Not Allowed) (RFA-MH-20-135)

Sponsor: National Institutes of Health

Award: Issuing IC and partner components intend to commit an estimated total of $4 million to fund three to seven awards in fiscal year 2020.

Due Date: September 27, 2019, and September 30, 2020, by 5 p.m. local time of applicant organization.

Environmental Influences on Aging: Effects of Extreme Weather and Disaster Events on Aging Processes (R01 Clinical Trial Not Allowed) (PAR-19-249)

Sponsor: National Institute on Aging; National Institute of Environmental Health Sciences; Office of Behavioral and Social Science Research

Due Date: July 8, 2019; November 4, 2019; March 9, 2020; July 6 , 2020; November 9, 2020; and March 8, 2021, by 5 p.m. local time of applicant organization.

Environmental Influences on Aging: Effects of Extreme Weather and Disaster Events on Aging Populations (R01 Clinical Trial Optional) (PAR-19-250)

Sponsor: National Institutes of Health

Due Date: July 8, 2019, November 4, 2019, March 9, 2020, July 7, 2020, November 9, 2020, March 8, 2021, apply by 5 p.m. local time of applicant organization.

Atomwise Artificial Intelligence Molecular Screen (AIMS) Awards

Sponsor: Atomwise, Inc.

Award: Up to $30,000 USD in assay support plus the cost of in silico screening and sourcing compounds.

Due Date: April 29, 2019

Accelerating Medicine Partnership in Parkinsons disease (AMP PD) unbiased proteomics biofluid analysis (U01 Clinical Trials Not Allowed) (RFA-NS-19-028)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: The National Institute of Neurological Disorders and Stroke intends to commit up to $3.4 million in FY19 to fund one award.

Due Date: May 29, 2019, by 5 p.m. local time of applicant organization.

NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional) (RFA-RM-19-005)

Sponsor: Office of Strategic Coordination (Common Fund)

Award: NIH intends to commit approximately $8 million in FY 2020 to fund approximately seven awards.

Due Date: September 9, 2019, by 5 p.m. local time of applicant organization.

NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional) (RFA-RM-19-006)

Sponsor: Office of Strategic Coordination (Common Fund)

Award: NIH intends to commit approximately $80 million for approximately 33 awards in fiscal year 2019.

Due Date: August 26, 2019, by 5 p.m. local time of applicant organization.

Limited Competition: Additional Sequencing for the Alzheimer's Disease Sequencing Project (U01 Clinical Trial Not Allowed) (PAR-19-234)

Sponsor: National Institute on Aging

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization.

2019 Part the Cloud: Translational Research Funding for Alzheimer’s disease (PTC)

Sponsor: Alzheimer's Association

Award: $750,000

Due Date: Letter of Intent Deadline: May 23,2019, 5 p.m. ET

Eric Kandel Young Neuroscientists Prize

Sponsor: The Hertie Foundation

Award: The prize includes a grant of €50,000 for personal use; a research budget of €50,000 for a scientific cooperation (partnership or mentoring) which extends the laureate’s area of research; and the invitation to give the Eric Kandel Prize Lecture at the FENS Forum 2020 in Glasgow, United Kingdom.

Due Date: May 1, 2019

2019 AFTD Nonpharmacological Therapies Pilot Grant

Sponsor: The Association for Frontotemporal Degeneration

Award: One award will be made in 2019 and will provide up to $60,000 (US) for one year (July 1, 2019 – June 30, 2020).

Due Date: The deadline for applications has been extended to April 19, 2019, at 5 p.m.

NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)

Sponsor: Office of Strategic Coordination (Common Fund)

Award: NIH Common Fund intends to commit approximately $8 million dollars in FY 2020 and make approximately seven awards, depending on the size and scope of the most meritorious awards.

Due Date: September 20, 2019, by 5 p.m. local time of applicant organization.

NIH Directors Early Independence Awards (DP5 Clinical Trial Optional) (RFA-RM-19-008)

Sponsor: Office of Strategic Coordination (Common Fund)

Award: The NIH Common Fund intends to commit approximately $4,000,000 to support approximately 10 awards in FY 2020, contingent upon availability of funds and receipt of a sufficient number of meritorious applications. Future year amounts will depend on annual appropriations and satisfactory progress.

Due Date: September 13, 2019, by 5 p.m. local time of applicant organization.